RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Retension Pharmaceuticals, Inc.
$16.33+2.26 (+16.06%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Retension Pharmaceuticals
Pharmaceutical Preparations, SIC 2834
Retension Pharmaceuticals, Inc. is listed on Nasdaq under the ticker RTSN, in the SEC industry Pharmaceutical Preparations. It is incorporated in Delaware and its fiscal year ends on December 31.
Company profile
Company
- Legal name
- Retension Pharmaceuticals, Inc.
- Headquarters
- Mclean, VA
- Address
- C/O Redux Therapeutics, Llc, 902 Turkey Run Road 22101
- Phone
- (703) 624-2024
- Website
- retensionpharmaceuticals.com
- Industry
- Pharmaceutical Preparations
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- RTSN
- Exchange
- Nasdaq
- IPO date
- Oct 9, 2026
- Filer category
- <br>Emerging growth company
- SEC CIK
- 2002988
- CUSIP
- 76135H100
- ISIN
- US76135H1005
- LEI
- 529900QBUEUWO67CZD11
- EIN
- 93-2592788
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Retension Pharmaceuticals's leadership is listed in its proxy statement (Form DEF 14A).
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 9, 2026 | IPO | Initial public offering priced (424B4 prospectus) |
| Oct 8, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |